Key Insights

Highlights

Success Rate

81% trial completion

Published Results

11 trials with published results (20%)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

13.0%

7 terminated out of 54 trials

Success Rate

80.6%

-6.0% vs benchmark

Late-Stage Pipeline

13%

7 trials in Phase 3/4

Results Transparency

38%

11 of 29 completed with results

Key Signals

11 with results81% success

Data Visualizations

Phase Distribution

34Total
Not Applicable (22)
P 1 (2)
P 2 (3)
P 3 (2)
P 4 (5)

Trial Status

Completed29
Terminated7
Recruiting6
Unknown6
Withdrawn2
Not Yet Recruiting2

Trial Success Rate

80.6%

Benchmark: 86.5%

Based on 29 completed trials

Clinical Trials (54)

Showing 20 of 20 trials
NCT07483879Recruiting

Biomarkers of Acute Organ Injury in Pediatric Newly Diagnosed Type 1 Diabetes

NCT07467616Not ApplicableCompletedPrimary

Impact of Clinical Nursing Guideline on Outcomes of Children With Diabetic Ketoacidosis.

NCT06693115Not ApplicableWithdrawnPrimary

Continuous Glucose Monitoring Using a New Subcutaneous Insulin Protocol for Mild to Moderate Diabetic Ketoacidosis

NCT07423559Not ApplicableCompletedPrimary

Relapse Among Diabetic Ketoacidosis Patients Maintained Basal Bolus Insulin Administration in Combination With Continuous Intravenous Insulin Infusion VS Non Maintaining Basal Insulin Patients

NCT06471322Not ApplicableTerminatedPrimary

A Multi-Disciplinary Technology-Based Care for Diabetic Ketoacidosis in Patients With Type 1 Diabetes

NCT07167693Phase 1Recruiting

Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes

NCT05402579Completed

Diabetic Ketoacidosis From New SGLT2i: Can Genomics Estimate Risk

NCT07193069Recruiting

Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning

NCT05752279Phase 3RecruitingPrimary

Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis

NCT07127406Active Not RecruitingPrimary

Postoperative Euglycemic Ketoacidosis Frequency in Sodium-Glucose Cotransporter-2 Inhibitor Users

NCT06186245Not ApplicableEnrolling By Invitation

Starvation in the Treatment of Diabetic Ketoacidosis

NCT06955416Phase 2RecruitingPrimary

REAMBERIN® 1.5% in Rehydration Therapy of Diabetic Ketoacidosis

NCT05443802Not ApplicableCompletedPrimary

Comparison of a Low Dose to a Standard Dose of Insulin in Adult DKA in ICU to Reduce Metabolic Complications

NCT05439928Not ApplicableCompletedPrimary

Remote Glucose Monitoring System in Hospitalized Patients With Diabetic Ketoacidosis (DKA)

NCT06748365RecruitingPrimary

Serum Ferritin and Prognosis of DKA

NCT04926740Not ApplicableCompletedPrimary

Intravenous Fluids in Adults With Diabetic Ketoacidosis in the Emergency Department

NCT04234867Phase 1Terminated

Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D)

NCT06516692Not ApplicableCompleted

Inferior Vena Cava Collapsibility and Distensibility Assessment in Critical Care.

NCT03660189Not ApplicableTerminatedPrimary

Two Bag System for Diabetic Ketoacidosis

NCT03717896Phase 2CompletedPrimary

Thiamine As Adjunctive Therapy for Diabetic Ketoacidosis

Scroll to load more

Research Network

Activity Timeline